ACADRA Trademark

Trademark Overview


On Wednesday, December 21, 2011, a trademark application was filed for ACADRA with the United States Patent and Trademark Office. The USPTO has given the ACADRA trademark a serial number of 79110292. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, December 21, 2021. This trademark is owned by Advancell Advanced In Vitro Cell Technologies,; S.A.. The ACADRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of leukemia; pharmaceutical preparations for the treatment of cancer; chemical reagents for medical purposes; chemical-pharmaceutical preparations for the treatment of oncological diseases and disorders; chemical-pharmaceutical preparations for the treatment of cancer; chemical-pharmaceutical preparations for the treatment of leukemia; chemical-pharmaceutical preparations for the treatment of immune system related diseases and disorders; chemical preparations for medical or pharmaceutical purposes, namely, anti-cancer preparations; chemical preparations for medical or pharmaceutical purposes, namely, preparations for the treatment of immune system related diseases and disorders; but none of the above goods including insulin or any products or preparations for the ...
acadra

General Information


Serial Number79110292
Word MarkACADRA
Filing DateWednesday, December 21, 2011
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, December 21, 2021
Registration Number4181569
Registration DateTuesday, July 31, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 15, 2012

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of leukemia; pharmaceutical preparations for the treatment of cancer; chemical reagents for medical purposes; chemical-pharmaceutical preparations for the treatment of oncological diseases and disorders; chemical-pharmaceutical preparations for the treatment of cancer; chemical-pharmaceutical preparations for the treatment of leukemia; chemical-pharmaceutical preparations for the treatment of immune system related diseases and disorders; chemical preparations for medical or pharmaceutical purposes, namely, anti-cancer preparations; chemical preparations for medical or pharmaceutical purposes, namely, preparations for the treatment of immune system related diseases and disorders; but none of the above goods including insulin or any products or preparations for the treatment of type 1 or type 2 diabetes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, March 8, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAdvancell Advanced In Vitro Cell Technologies, S.A.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressE-08028 Barcelona
ES

Party NameAdvancell Advanced In Vitro Cell Technologies,; S.A.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressES

Party NameAdvancell Advanced In Vitro Cell Technologies,; S.A.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressES

Trademark Events


Event DateEvent Description
Sunday, July 17, 2022NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Saturday, July 16, 2022DEATH OF INTERNATIONAL REGISTRATION
Friday, January 3, 2020TOTAL INVALIDATION PROCESSED BY THE IB
Monday, December 2, 2019GENERIC MADRID TRANSACTION SENT TO IB
Monday, December 2, 2019GENERIC MADRID TRANSACTION CREATED
Friday, November 8, 2019TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Thursday, May 23, 2019NEW REPRESENTATIVE AT IB RECEIVED
Friday, March 8, 2019CANCELLED SECTION 71
Sunday, November 4, 2012NOTIFICATION PROCESSED BY IB
Monday, September 24, 2012FINAL DISPOSITION NOTICE SENT TO IB
Monday, September 24, 2012FINAL DISPOSITION PROCESSED
Thursday, August 30, 2012GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, July 31, 2012REGISTERED-PRINCIPAL REGISTER
Tuesday, May 15, 2012PUBLISHED FOR OPPOSITION
Wednesday, April 25, 2012NOTICE OF PUBLICATION
Saturday, April 14, 2012APPLICATION FILING RECEIPT MAILED
Wednesday, April 11, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 10, 2012ASSIGNED TO EXAMINER
Tuesday, April 10, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, April 9, 2012LIMITATION FROM ORIGINAL APPLICATION ENTERED
Friday, April 6, 2012SN ASSIGNED FOR SECT 66A APPL FROM IB